Ahmad Haroon

Dr. Ahmad Haroon is an Assistant Professor at the University of Maryland School of Medicine with primary appointments in the Department of Neurology and secondary appointments in Neurosurgery. He is an Associate Member of the Greenbaum Cancer Center and specializes in central nervous system tumors, including glioblastoma, meningioma, and metastases. As a board-certified neurologist, he treats stroke, epilepsy, and headache disorders.

• Education: BS in Biochemistry and Molecular Biology (University of Maryland, 2007); MD (University of Virginia, 2012); ORISE Fellowship (FDA, 2013); Internal Medicine Internship (East Carolina University, 2014); Neurology Residency (Rutgers-Robert Wood Johnson, 2017); Neuro-Oncology Fellowship (University of Virginia, 2019)

Dr. Haroon’s research focuses on brain and spinal cord tumors, immunotherapy (checkpoint inhibitors, Car-T cells), and radiation therapy (proton therapy, radiation necrosis). His work includes clinical trials on gliomas, meningiomas, and CNS lymphoma.

His publications highlight trends in high-grade gliomas, radiation necrosis, and checkpoint inhibitor toxicity. He contributes to guidelines on immunotherapy management.

Professional Affiliations:

• Board-Certified Neurologist
• Weekly Tumor Board Member (UMMC neuro-oncology team)
• Advocate for Maryland State Patient Care